15 Overstated
As little as 10 minutes of vigorous-intensity exercise immediately increases neuronal connectivity and improves executive function by approximately 14%, translating to about a 50-millisecond improvement in processing speed.
"there's been studies showing that you have an improvement in executive function by like 14%, which is pretty big. I think it was like a 50-millisecond improvement processing speed or something which doesn't sound a lot, but actually translates to a big improvement in executive function." (said at 0:11:59)
The speaker appears to refer to acute exercise trials such as Samani & Heath (2018; PMID: 29191783), which evaluated executive control using an antisaccade oculomotor task before and after a 10-minute bout of moderate-to-vigorous cycling in healthy young adults. The study found a statistically significant ~27-millisecond reduction in reaction time (an improvement of roughly 10–14%), rather than a 50-millisecond change. While the general direction and approximate percentage match published laboratory findings, generalizing transient reductions in saccadic reaction time in a small sample to broad, lasting improvements in processing speed and executive function is overstated.
The anterior midcingulate cortex is hyperplastic throughout the lifespan and enlarges when individuals perform tasks they find effortful and dislike doing.
"the anterior midcingulate cortex is the brain area that is hyperplastic throughout the lifespan, which is rare for a brain area, and it enlarges um when we do things we don't want to do. It's not just about doing hard things. It's about It's about doing the hard thing you hate." (said at 0:24:36)
The anterior midcingulate cortex (aMCC) is widely described in neuroimaging and cognitive neuroscience literature as a critical structural and functional hub for tenacity, cognitive control, allostatic energy regulation, and persistence in the face of challenge (Touroutoglou et al., 2020; Touroutoglou et al., 2019). However, the specific claim that the aMCC is uniquely 'hyperplastic throughout the lifespan' and that it directly 'enlarges' when individuals perform tasks they subjectively dislike or 'hate' takes conceptual models of effort valuation and cross-sectional neuroimaging findings and overstates them as established anatomical growth mechanisms.
Studies show that high-dose glutamine supplementation (approximately 30 g) reduces the incidence of respiratory tract infections in endurance athletes.
"there's a few studies out there showing that if these athletes take a higher dose of glutamine—I think it's like 30 g or something high like that—that they had a lower incidence of respiratory tract infections than the ones that weren't doing it." (said at 0:51:22)
While early small studies by Castell et al. (1996, 1997) reported that post-exercise oral glutamine supplementation (typically two 5 g doses, totaling 10 g, rather than 30 g) significantly reduced the incidence of self-reported upper respiratory tract infections in endurance runners and rowers, subsequent systematic reviews and broader evidence syntheses have found that glutamine does not reliably alter immune parameters or prevent upper respiratory tract infections in athletes.
- contradicts: Nutritional modulation of exercise-induced immunodepression in athletes: a systematic revi… (European journal of clinical nutrition 2007) · cited 82x in the literature
"Twenty studies addressed carbohydrate supplementation, eight glutamine, 13 vitamin C and four others interventions... The available evidence failed to support a role for other nutritional supplements in preventing exercise-induced immune suppression." (abstract, results and conclusions)
pubmedfull study (doi) - supports: Does glutamine have a role in reducing infections in athletes? (European journal of applied physiology and occupational physiology 1996) · cited 204x in the literature
"In the present study, athletes participating in different types of exercise consumed two drinks, containing either glutamine (Group G) or placebo (Group P) immediately after and 2 h after exercise. They subsequently completed questionnaires (n = 151) about the incidence of infections during the 7 days following the exercise. The percentage of athletes reporting no infections was considerably higher in Group G (81%, n = 72) than in Group P (49%, n = 79, p < 0.001)." (abstract, results, passage verified)
pubmedfull study (doi)
A clinical study showed that N-acetylcysteine (NAC) supplementation significantly reduced the rate of contracting influenza upon exposure compared to placebo, dropping infection from the high 70% range to around the high 20% range.
"There's at least one study showing that it reduced flu transmission where people were deliberately exposed to flu. I think it took the number of people that contracted flu compared to the placebo group somewhere from the high 70% area—I don't remember the exact number now, we'll put a link to the study—down to maybe high 20s, which is pretty impressive." (said at 0:55:10)
The speaker refers to a well-known 1997 randomized, double-blind, placebo-controlled trial by De Flora et al. (PMID: 9230243) evaluating 6 months of oral NAC (600 mg twice daily) in 262 individuals. However, the speaker misrepresents two key aspects of the study. First, it was not a human challenge study with deliberate viral exposure, but an evaluation during natural winter exposure in community-dwelling older adults (78% aged ≥65). Second, NAC did not reduce the rate of contracting the virus (influenza transmission/seroconversion rates were similar between groups). Rather, among individuals who became infected (seroconverted to A/H1N1), only 25% developed symptomatic influenza-like illness in the NAC group compared to 79% in the placebo group.
Studies by Satchin Panda show that stopping eating three hours before bed improves sleep.
"I know Satchin Panda, he's been on my podcast, your podcast. He's had studies showing that it seemed like stop stop eating 3 hours before bed really does seem to improve sleep." (said at 1:03:24)
Dr. Satchin Panda's research group has investigated time-restricted eating (TRE) and circadian meal timing, frequently recommending that individuals finish eating 2 to 4 hours before sleep to support circadian alignment. However, claiming his studies demonstrated that stopping eating 3 hours before bed definitively improves sleep overstates the findings. In human clinical pilot studies co-authored by Panda evaluating TRE (such as 8-to-10-hour eating windows that reduce late-night eating), primary objective sleep metrics (e.g., actigraphy) generally did not show significant improvements from baseline, although greater eating window restriction was associated with longer sleep duration and participants subjectively reported improved sleep quality. The available clinical evidence from these trials is preliminary, consisting of small pilot samples.
Scientific evidence shows that deliberate cold exposure increases adrenaline and peripheral dopamine while lowering cortisol.
"there's also this idea that deliberate cold exposure increases cortisol, but when you look at the data, it definitely increases adrenaline and peripheral dopamine and probably—I'll go on record, probably central dopamine, although we don't have as good evidence for that yet. But the evidence points to the fact that deliberate cold exposure lowers cortisol." (said at 1:09:13)
The claim overstates and partially conflates the hormonal effects of cold exposure. In the landmark human trial examining this (Šrámek et al., 2000, n=10), 1-hour immersion in 14°C cold water caused large increases in plasma noradrenaline (530%) and dopamine (250%), but plasma adrenaline (epinephrine) concentrations remained unchanged. Furthermore, while cortisol did not increase and tended to decline slightly during immersion in that trial (a phenomenon largely attributed to hydrostatic pressure and circadian drift rather than cold per se), other cold-exposure studies show cortisol either remains unchanged or increases depending on the severity of the cold, shivering, and exercise conditions.
- partial: Human physiological responses to immersion into water of different temperatures. (European journal of applied physiology 2000) · cited 345x in the literature
"Cold water immersion (14 degrees C) lowered rectal temperature and increased metabolic rate (by 350%), heart rate and systolic and diastolic blood pressure (by 5%, 7%, and 8%, respectively). Plasma noradrenaline and dopamine concentrations were increased by 530% and by 250% respectively, while diuresis increased by 163% (more than at 32 degrees C)... Cortisol concentrations tended to decrease. Plasma adrenaline concentrations remained unchanged." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Aerobic power and body size affects the exercise-induced stress hormone responses to varyi… (Aviation, space, and environmental medicine 1994) · cited 9x in the literature
"Plasma CO (exercise - rest) increased during the 20 degrees C trials and decreased during the 30 and 35 degrees C trials (p = 0.011)." (abstract, results, passage verified)
pubmed
High levels of visceral fat are associated with double the risk of early death.
"It's associated with double the increased risk double the risk of early death." (said at 1:13:08)
While elevated visceral adipose tissue (VAT) is associated with an increased risk of all-cause mortality, stating that it doubles the risk is an overstatement. In a large systematic review and dose-response meta-analysis (PMID 35717418), each 1-SD increment in VAT was associated with a 17% increase in all-cause mortality (HR 1.17, 95% CI: 1.03–1.33). Another systematic review (PMID 36082075) observed an 11% to 98% relative risk increase across cohorts of adults aged ≤65 years, but noted that the association frequently lost statistical significance after adjusting for BMI and glycemic parameters and was inconsistent in adults over 65 years. The evidence is derived from observational cohorts prone to residual confounding.
- partial: Body fat and risk of all-cause mortality: a systematic review and dose-response meta-analy… (International journal of obesity (2005) 2022) · cited 95x in the literature
"The HRs were 1.06 (95%CI: 1.01, 1.12; I 2 = 86%, n = 10) for a 5 kg increment in FM, 1.11 (95%CI: 1.06, 1.16; I 2 = 79%, n = 7) for a 2 kg/m 2 increment in FMI, and 1.17 (95%CI: 1.03, 1.33; I 2 = 72%, n = 8) and 0.81 (0.66, 0.99; I 2 = 59%, n = 6) for a 1-SD increment in VAT and SAT, respectively." (abstract, results)
pubmedfull study (doi) - partial: Abdominal Visceral Adipose Tissue and All-Cause Mortality: A Systematic Review. (Frontiers in endocrinology 2022) · cited 51x in the literature
"Six cohorts with a mean age ≤ 65 years, examining all-cause mortality risk per increment in VAT area (cm 2 ) or volume (cm 3 ), showed a 11-98% relative risk increase with higher VAT parameters. However, the association lost significance after adjusting for glycemic indices, body mass index, or other fat parameters." (abstract, results)
pubmedfull study (doi)
Unlike subcutaneous fat, visceral fat lipolysis does not shut down in response to insulin, continually releasing free fatty acids to the liver via the portal vein.
"Visceral fat is very different from subcutaneous fat because it doesn't respond to insulin like subcutaneous fat does. In other words, when you have a meal, you eat a carbohydrate meal, and basically your body increases insulin to help take up glucose into your liver, muscle, adipose tissue, lipolysis shuts down, right? So, "Okay, no longer am I going to break down these fats, it's time to use this energy," right? Visceral fat doesn't respond to insulin, so it just keeps going, right?" (said at 1:14:47)
The speaker overstates a relative physiological difference as an absolute one. Visceral (omental) adipose tissue is significantly less sensitive to the antilipolytic actions of insulin compared to subcutaneous adipose tissue, leading to a higher rate of lipolysis and free fatty acid flux to the liver via the portal vein. However, visceral fat is not completely unresponsive to insulin; rather, it exhibits lower insulin sensitivity and higher catecholamine responsiveness compared to subcutaneous depots.
A recent study by Mark Mattson found that a 5:2 intermittent fasting protocol (restricting calories to ~500 on 2 days per week) resulted in a 20% improvement across a battery of cognitive tests compared to a standard calorie-restricted healthy diet.
"Mark Mattson just published a study very very recently showing that he did a I think he was doing a 5:2 intermittent fasting protocol where it's like 2 days you're getting pretty severe caloric restriction. Like you're eating one meal, but it's like 500 calories, you know, for that for the day. And it's twice 2 days 2 days out of the week. The other 5 days you're eating normal and compared that to calorie like eating eating like a healthy diet and they were somewhat calorie restricted but not quite as much as the people that were doing the fasting and they had the fasting group had massive cognitive benefits like 20% improvement in a battery of tests that were done." (said at 1:32:22)
A 2024 randomized controlled trial co-authored by Mark Mattson (PMID 38901423) tested an 8-week 5:2 intermittent fasting protocol against a healthy living diet in 40 older adults with insulin resistance. The trial found that both diets improved executive function and memory, with 5:2 intermittent fasting benefiting certain cognitive sub-measures more than the healthy living diet. However, describing this as a 'massive cognitive benefit' or a uniform '20% improvement across a battery of cognitive tests' overstates the findings of this small pilot trial (n=40), where both dietary interventions showed comparable improvements across multiple neurobiological and cognitive endpoints.
Performing 10 bodyweight squats every 45 minutes across a 7.5-hour workday is more effective at regulating blood glucose levels than a single continuous 30-minute walk.
"showing that getting up and doing 10 bodyweight squats every 45 minutes over a 7 and 1/2 hour work day is better at regulating blood glucose levels than a 30-minute walk, right?" (said at 1:49:23)
Studies evaluating interrupted sitting across laboratory-based workday models (typically 7.5 to 8 hours) show that frequent bodyweight resistance breaks (such as 10–15 chair stands or squats every 20–30 minutes) reduce postprandial insulinemia and, in individuals with type 2 diabetes, glucose excursions compared to continuous uninterrupted sitting. However, trials comparing intermittent bodyweight squats specifically to a continuous 30-minute walk across a 7.5-hour day do not demonstrate superior blood glucose regulation for squats; in healthy adults, 15 chair stands every 30 minutes reduced postprandial insulin area under the curve compared with prolonged sitting without significantly altering plasma glucose concentrations.
- partial: Effects of breaking up sedentary time with "chair squats" on postprandial metabolism. (Journal of sports sciences 2019) · cited 21x in the literature
"In one trial (SIT) participants sat continuously throughout the observation period; in the "Chair squat" trial (SIT/STAND), participants performed "chair squats" (10 × standing and sitting over 30 seconds, every 20 minutes)... Postprandial insulin concentrations over the post-breakfast period were 10.9 ± 8.4% lower in SIT/STAND than SIT (p = 0.047), but did not differ between trials in the post-lunch period. Glucose and triglyceride concentrations did not differ significantly between trials." (abstract, results)
pubmedfull study (doi) - partial: Interrupting prolonged sitting with repeated chair stands or short walks reduces postprand… (Journal of applied physiology (Bethesda, Md. : 1985) 2021) · cited 29x in the literature
"Fourteen participants (7 males, 7 females; 24 ± 5 yr; 25 ± 5 kg/m 2; 40 ± 8 mL/kg/min; 7,033 ± 2,288 steps/day) completed three 7.5-h trials in a randomized order consisting of uninterrupted sitting (SIT), sitting with intermittent (every 30 min) walking (WALK; 2 min at 3.1 mph), or sitting with intermittent squats (SQUAT; 15 chair stands with calf raise)... Postprandial glucose and insulin did not differ across conditions following breakfast... Here, we demonstrated that interrupting prolonged sitting every 30 min with 1 min of repeated chair stands was as effective as 2-min treadmill walks for lowering postprandial insulinemia in healthy adults." (abstract, results and conclusions)
pubmedfull study (doi)
Studies show that giving approximately 20 grams of creatine to older adults with mild cognitive impairment or early-stage Alzheimer's disease improves cognitive function.
"There've been studies coming out since then showing that, okay, if you give older adults with mild cognitive impairment, perhaps mild, you know, early stage Alzheimer's disease, again, 20 grams, you're giving them in the 20 g range of creatine, it's improving their cognitive function." (said at 2:14:33)
The speaker's claim refers to findings from an early pilot study testing ~20 g/day of creatine monohydrate in Alzheimer's disease, but overstates the strength of the evidence. Specifically, the only clinical study evaluating 20 g/day in AD patients (the CABA pilot trial, n=20) was a small, single-arm feasibility pilot without a placebo control group. While participants showed statistically significant improvements on certain cognitive composites and tests over 8 weeks, the lack of a control group means re-test/practice effects cannot be ruled out, and definitive efficacy has not yet been demonstrated in randomized controlled trials.
- partial: Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition. (Alzheimer's & dementia (New York, N. Y.) 2025) · cited 13x in the literature
"In this single-arm pilot trial, we investigated the feasibility of 20 g/day CrM for 8 weeks in 20 patients with AD... Cognition improved on global ( p = .02) and fluid ( p = .004) composites, List Sorting ( p = .001), Oral Reading ( p < .001), and Flanker ( p = .05) tests." (abstract, results)
pubmedfull study (doi) - context: Bioenergetic data from a creatine monohydrate pilot trial in Alzheimer's disease. (Alzheimer's & dementia (New York, N. Y.) 2026)
"Interpretation of results from this pilot study is limited by lacking a control group, small sample size, and its relatively short timeframe. However, these preliminary findings support further investigation of CrM as a potential bioenergetic intervention in AD with well-designed RCTs, including exploration of potential sex-specific bioenergetic responses to CrM." (abstract, conclusions, passage verified)
pubmedfull study (doi)
A high omega-3 index is associated with a 5-year increased life expectancy and a 90% reduction in sudden cardiac death.
"5-year increased life expectancy if you're on the high end. Um you're talking about 90% reduction in sudden cardiac death." (said at 2:22:30)
The speaker's figures refer to observational cohort findings rather than established clinical trial outcomes. The ~5-year difference in life expectancy is derived from statistical modeling of the Framingham Offspring Cohort (PMID: 34134132, PMID: 29559306), where individuals in the highest quintile of the Omega-3 Index had a 34% lower risk of all-cause mortality compared to the lowest quintile (an effect size comparable to roughly 4.7-5 years of life expectancy or the gap between smokers and non-smokers). Similarly, the ~90% reduction in sudden cardiac death refers to observational cohort analyses comparing extreme quantiles of baseline blood omega-3 levels (e.g., the Physicians' Health Study), whereas pooled meta-analyses of prospective cohorts and trials indicate a more modest ~15% to 30% reduction in fatal coronary events (PMID: 28511049). Presenting these observational associations as direct life expectancy gains and 90% risk reductions overstates the evidence.
In a clinical trial (the DO-HEALTH trial), omega-3 supplementation alone reduced the rate of pre-frailty by approximately 16%.
"three months slowing the epigenetic aging clock by omega-3 only is going to get you like, you know, 16% lower pre-frailty... And then the pre-frailty was the omega-3 alone" (said at 2:27:54)
In the DO-HEALTH randomized clinical trial (Bischoff-Ferrari et al., 2023), omega-3 supplementation alone did not produce a statistically significant reduction in the odds of incident pre-frailty over 3 years. The authors reported that 'Odds ratios for becoming pre-frail were not significantly lower for vitamin D3, or omega 3-s, or SHEP, individually, compared to control', whereas only the combination of all three treatments (vitamin D3, omega-3, and exercise) achieved a statistically significant reduction (OR 0.61, p=0.04). While exploratory point estimates for omega-3 alone may have hovered around an OR of 0.84 (~16% lower odds), presenting this as a proven reduction from omega-3 alone overstates a non-significant result.
Nicotinamide riboside (NR) is involved in improving fertility, sperm health, and egg health by improving mitochondrial health.
"If you can improve mitochondrial health, fertility, which is why NR is now involved with fertility. It seems to be improving fertility. It's right. If you can improve mitochondrial health, then you're going to improve fertility, sperm health, right? Egg health, right?" (said at 3:07:21)
Preclinical animal and in vitro models demonstrate that nicotinamide riboside (NR) supplementation boosts cellular NAD+ levels, enhances mitochondrial function, reduces oxidative stress, and improves oocyte (egg) quality, live birth rates, and sperm parameters in aged, diabetic, or genetically impaired rodents and boars. However, stating definitively that NR improves human fertility, sperm health, and egg health overstates the evidence, as robust randomized controlled trials in humans are lacking.
- supports: Increasing ovarian NAD + levels improve mitochondrial functions and reverse ovarian aging. (Free radical biology & medicine 2020) · cited 127x in the literature
"NR supplementation also reduced levels of reactive oxygen species and decreased spindle anomalies in aging oocytes, together with increased mitochondrial membrane potential (ΔΨm) and decreased mitochondrial clustering. In addition, NR supplementation improved ovarian mitochondrial energy metabolism." (abstract, results)
pubmedfull study (doi) - supports: BNC1 deficiency induces mitochondrial dysfunction-triggered spermatogonia apoptosis throug… (Biology of reproduction 2024) · cited 13x in the literature
"Administration of nicotinamide riboside or metformin reversed mitochondrial dysfunction and inhibited apoptosis in Bnc1-knockdown spermatogonia by stimulating CREB/SIRT1/FOXO3 signaling. Dietary supplementation with nicotinamide riboside or metformin in mutated mice increased SIRT1 signaling, improved the architecture of spermatogenic tubules, inhibited apoptosis of the testis, and improved the fertility of mice with a Bnc1 truncation mutation." (abstract, results, passage verified)
pubmedfull study (doi) - context: NAD + precursors mitigate the in vitro and in vivo reproductive defects: Limitations and p… (Reproductive toxicology (Elmsford, N.Y.) 2025) · cited 2x in the literature
"This review summarizes that the natural aging process, diseases, and toxic compounds cause the detrimental effects in the reproductive parameters of the in vivo models, such as the meiotic defects and the reductions in cellular NAD + level, mitochondrial functions, sperm and oocyte quality, blastocyst and embryo formation rate, implantation success, whereas the intragastric, intraperitoneal or oral administration of NAD + precursors prevents or attenuates these detrimental effects." (abstract, results, passage verified)
pubmedfull study (doi)
Literature shows that creatine supplementation in young children participating in sports like soccer improves agility and is safe.
"Yeah, so there is data in the literature showing that if you give younger younger children that are doing like, for example, sports like soccer, it does seem to improve their agility. And it seems to be safe." (said at 3:23:24)
While some literature reviews of adolescent athletes note a general lack of adverse events and potential performance benefits, the evidence specifically supporting agility improvements and safety in young children is weak and inconsistent. A meta-analysis of soccer players (PMID 30935142) found that creatine supplementation did not significantly improve phosphagen-system performance tests, which included agility (p = 0.08). Furthermore, a systematic review of pediatric and adolescent athletes (PMID 37008451) concluded that the overall quality of studies is poor, there are no consistent performance benefits, and no studies have been designed to properly evaluate safety.
- contradicts: Effects of Creatine Supplementation on Athletic Performance in Soccer Players: A Systemati… (Nutrients 2019) · cited 86x in the literature
"This revealed that creatine supplementation did not present beneficial effects on aerobic performance tests (SMD, -0.05; 95% confidence interval (CI), -0.37 to 0.28; p = 0.78) and phosphagen metabolism performance tests (strength, single jump, single sprint, and agility tests: SMD, 0.21; 95% confidence interval (CI), -0.03 to 0.45; p = 0.08)." (abstract, results, passage verified)
pubmedfull study (doi) - context: Creatine Supplementation in Children and Adolescents. (Nutrients 2021) · cited 47x in the literature
"While limited in scope, studies involving creatine supplementation and exercise performance in adolescent athletes generally report improvements in several ergogenic outcomes with limited evidence of ergolytic properties and consistent reports indicating no adverse events associated with supplementation." (abstract, passage verified)
pubmedfull study (doi) - contradicts: Creatine supplementation in the pediatric and adolescent athlete-- A literature review. (Journal of orthopaedics 2023) · cited 9x in the literature
"The overall quality of the studies was poor, and there were no consistent findings regarding creatine supplementation and improvements in athletic performance. No studies were designed to address the topic of safety." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.